1. AMP-activated protein kinase induces apoptosis in LX2 cells involving of Bax pathway

2. Background
Result
Possible mechanism
Next works

3. Background
Hepatic stellate cells (HSCs) are a major fibrogenic cell type which contributes to extracellular matrix accumulation during chronic liver diseases.
HSCs also play a critical role in the resolution of hepatic fibrosis, where activated HSCs take place apoptosis.
So inducing apotosis of HSCs is a potential therapic strategy for hepatic fibrosis.

4. Recent evidence has indicated that AMP-activated protein kinase (AMPK) can induce apoptosis of several kinds of cells, such as rat liver cells, MIN6 cells and human neuroblastoma cells, but little is known regarding this matter in HSCs.

5. AMPK
AMPK is a serine/threonine protein kinase, composed of a catalytic subunit (α) and two regulatory subunits (βandγ) .
AMPKα residues no longer associates with theβandγsubunits but retaines significant kinase activity .
Mutation of thronine 172 within theαsubunit to an asparitic acid residue within this truncated protein prevent its inactivation by protein phosphatases.

6. Result Adenovirus-mediated expression of AMPKα1 312
AMPKα1 312 should be expressed between 48h and 72h, and the activity can sustain to 72 at least.

7. Expression of constitutively active AMPK induces apoptosis in LX2 cell
DNA ladder appeared after expression of constitutively active AMPK
Lane1: Marker
Lane2: treated with Ad-CA-AMPK
Lane3: treated with Ad-Luc
Lane4: treated with H2O2
Lane5: blank control

8. Apoptotic peak appeared after expression of constitutively active AMPK
Blank control
Ad-Luc
Ad-CA-AMPK
Group apoptosis rate（％）
Control ±0.389
Ad-Luc ±0.141
Ad-CA-AMPK ±7.762*#
* vs to control; # vs to Ad-Luc

9. Bax was up-regulated with the over-expression of AMPK
Pro-caspase-3 was activated and bax was upregulated
Bcl-2 is expressed at a low level

10. Bax was knocked down by RNAi
RNAi for Bax

11. RNAi + Ad-Luc RNAi + Ad-CA-AMPK Ad-CA-AMPK
Cell phenotype changes after RNAi for Bax and infection of adenoviruses
RNAi + Ad-Luc
RNAi + Ad-CA-AMPK
Ad-CA-AMPK

12. Activation of caspase-3 induced by AMPK recovered with RNAi for Bax

13. Possible mechanisms AMPK AMPK JNK P P ACC c-Jun P Cyto c Malonyl-CoA
Caspase-9
Respiratory china
bax
β-oxidation
Caspase-3,6,7
Oxidative stress
Apoptosis

14. 下步的工作 进一步证实AMPK是不是通过JNK通路激活了Bax，诱导凋亡。 动物试验 1. 建模后尾静脉注射Ad-CA-AMPK,
2. Metformin，TZDs喂食动物,分析其对肝纤维化的影响。
调查，统计分析： Metformin, TZDs在治疗糖尿病患者时是否对与同时患有肝炎的人同样具有治疗作用。

15. Thank you！

16. Metformin:二甲双胍，通过抑制糖原异生及糖原的分解，可降低糖尿病时的高肝糖生成率。
TZDs：噻唑烷二酮，也称格列酮类药物，增强靶组织对胰岛素的敏感性。其中TRG（曲格列酮）可引起肝损伤,同类药物还有RSG(罗格列酮), PIO(帕格列酮)。

17. Following chronic liver injury, HSCs proliferate and transform to a myofibroblast-like phenotype secreting large amounts of extracellular matrix proteins and tissue inhibitor of metalloproteinase（TIMP).

18. Consequences of hepatic AMPK activation
Consequences of hepatic AMPK activation. The pharmacologic agents, metformin and thiazolidinediones (TZDs), activate AMPK in the liver. In addition, the deletion of SCD results in AMPK activation through an undetermined mechanism. The activation of AMPK reduceslipogenesis through three independent mechanisms. Activated AMPK phosphorylates and inhibits the activity of ACC, which reduces malonyl-CoA formation. ChREBP is phosphorylated by activated AMPK, which inhibits its entry into the nucleus, thus suppressing L-PK and lipogenic gene expression. SREBP-1c expression is reduced by activated AMPK through undefined mechanisms. The cumulative result of AMPK activation, whether by drugs or through the deletion of SCD, is a reduction in fatty acid synthesis, decreased malonyl-CoA concentrations, and increased CPT-1 activity, resulting in increased fatty acid oxidation.